Periodic Safety Update Report system draws varying reactions

Pharmaceutical companies have disclosed varying views with reference to Periodic Safety Update Reports (PSUR) the Korea Food and Drug Administration aims to introduce as part of its efforts to provide an update of the worldwide safety experience of a medicinal product to competent authorities at defined time points post-authorization.

If it implanted, market authorization (MA) holders are ob...